Literature DB >> 6268714

A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3.

M P Reyes, K L Ho, F Smith, A M Lerner.   

Abstract

Myocardial scarring was induced in 111 mice (group 3) inoculated at 14 days of age with coxsackievirus B3 and forced to swim for 30 min daily during the initial nine days of infection. The animals were observed until age 15 months. Control animals included mice infected but not forced to swim (group 2), neither infected nor forced to swim (group 1), and not infected but forced to swim (group 4). The cumulative mortality was 45% among mice in group 3 but was significantly lower in the control animals. At 15 months, mice in group 3 showed heavy deposits of calcium in the injured myocardium, atrial hypertrophy with thrombi, and myocardial fiber disintegration with replacement by fibrous scar. Mononuclear infiltration was no longer present. Pathologic changes were concentrated in the left ventricle, interventricular septum, and atrioventricular junction. Titers of type-specific neutralizing antibodies had declined to one-fifth the level present at one month. These findings represent a model of dilated-type cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268714     DOI: 10.1093/infdis/144.3.232

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

Authors:  M W Cunningham
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.

Authors:  R J Kiel; F E Smith; J Chason; R Khatib; M P Reyes
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

3.  Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model.

Authors:  C J Gauntt; H M Arizpe; J T Kung; K K Ogilvie; U O Cheriyan
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

4.  Chronic neonatal coxsackie myocarditis.

Authors:  A Goren; M Kaplan; J Glaser; M Isacsohn
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

Review 5.  Diagnosing and treating active myocarditis.

Authors:  J B O'Connell; J W Mason
Journal:  West J Med       Date:  1989-04

Review 6.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

7.  Intracardiac thrombus in murine Coxsackievirus B3 myocarditis.

Authors:  C Kishimoto; H Ochiai; S Sasayama
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

8.  Use of the polymerase chain reaction with a murine model of picornavirus-induced myocarditis.

Authors:  I Leparc; F Fuchs; H Kopecka; M Aymard
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

Review 9.  The enteroviruses: recent advances.

Authors:  H A Wenner
Journal:  Yale J Biol Med       Date:  1982 May-Aug

Review 10.  Infection in athletes.

Authors:  I K Brenner; P N Shek; R J Shephard
Journal:  Sports Med       Date:  1994-02       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.